Dr Margaret Chua has been a Consultant Radiation Oncologist at Peter MacCallum Cancer Centre since 2003 and is currently Head and Clinical Lead of the Skin and Melanoma Radiation Oncology Unit. She has over 14 years’ experience in the management of skin cancers with a special interest in Merkel cell carcinoma and Melanoma.
Margaret completed her undergraduate medical degree at the University of New South Wales and postgraduate training in Radiation Oncology at Westmead Hospital in Sydney. In 2002/2003, she undertook a clinical research Fellowship in Head and Neck cancers with a special focus in nasopharyngeal carcinoma at Prince of Wales Hospital in Hong Kong. Upon return to Australia at the end of 2003, Margaret was appointed a full time joint consultant position in the Head and Neck Unit and the Skin and Melanoma Unit.
She is currently working part-time in the Skin and Melanoma Unit since 2010 following the birth of her children.
Margaret is a member of the ANZMTG (Australia and New Zealand Melanoma Trials Group) and AMIGOS (Australasian Merkel Cell Cancer Interest Group). She is an active collaborator in a number of national and international trials as principal and associate investigator. She is on the Trial Management Committee of past and present TROG (Trans-Tasman Radiation Oncology Group) multicentre trials investigating the role of adjuvant radiotherapy in patients with nodal involvement of melanoma and melanoma with neurotropism of the head and neck. She is the site principal investigator of the prospective study on the role of sentinel node biopsy in early stage Merkel cell carcinoma.
In her leadership role, Margaret has completed the Executive Ready program at the Australian School of Applied Management, one of Australia’s most respected providers of management and leadership education.